Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

With a December 11 federal funding deadline looming, the Child Neurology Society (CNS) is ramping up advocacy on Capitol Hill. CNS is pressing lawmakers on NIH research funding, Medicare telehealth access, prior authorization reform, physician workforce shortages, and vaccine policy. New HHS vaccine safety reporting initiatives and shifts in childhood immunization recommendations are also on the radar for child neurologists.
With a December 11 federal funding deadline fast approaching, Congress is working to resolve FY 2027 appropriations while a host of healthcare priorities hang in the balance. The Child Neurology Society (CNS) is making its voice heard, engaging lawmakers at its Annual Meeting and holding a direct meeting with Rep. Raul Ruiz's office to push key issues affecting children with neurological conditions.
CNS's advocacy agenda is wide-ranging. The society has been vocal on sustained NIH research funding, expanded Medicare telehealth access, prior authorization reform, physician workforce shortages, and vaccine policy — including submitting formal comments to HHS urging evidence-based, timely vaccination for children with complex neurological conditions. Meetings with Sen. Tammy Duckworth's office in September further underscored CNS's commitment to rare neurological disease support and telehealth continuity.
Key Takeaways:
Why it matters: Policy decisions made in this lame-duck session could directly shape research funding, care access, and vaccination programs for some of the most vulnerable pediatric patients — making CNS's advocacy efforts especially timely.